RxDoctor Payments Data

Bryan Stone, DO

Gastroenterology · Doylestown, PANPI 1891291134

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AbbVie at 53.4% of the total. Reporting peaked in 2024 at $356 and has fallen 64.4% since, to $127 in 2025. That places this record below the midpoint for gastroenterology clinicians in PA, where the typical reported total is $1,806.

$1,315in general payments, 2019–2025

Across 40 payments — averaging $32.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$703
  • Medtronic$203
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$134
  • Bristol Myers Squibb$69
  • Aimmune Therapeutics, Inc.$66
  • Johnson & Johnson$40
  • plus $100 from 5 others

What the payments were for

  • Food & beverage$1,315100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,315 in reported general payments places this provider in the 45th percentile of 935 gastroenterology providers in Pennsylvania.

See all gastroenterology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$44,907
Medicare patients
135
Services billed
303

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg23$441
Pantoprazole Sodium31$355
Omeprazole12$238
Famotidine15$219

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Doylestown

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →